{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:45:18Z","timestamp":1725378318810},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.arteri.2015.12.003","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T23:59:23Z","timestamp":1456963163000},"page":"132-140","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Consenso Delphi sobre el manejo de la dislipidemia en pacientes con alteraci\u00f3n del metabolismo de la glucosa: estudio Diana"],"prefix":"10.1016","volume":"28","author":[{"given":"Juan","family":"Pedro-Botet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivencio","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F.","family":"Ascaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleix","family":"Cases","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalberto","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2015.12.003_bib0130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.12.003_bib0135","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.12.003_bib0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.12.003_bib0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.arteri.2015.12.003_bib0150","first-page":"S834","article-title":"High-dose atorvastatin associated with worse glycemic control: A PROVE-IT TIMI 22 substudy (Abstract)","volume":"110","author":"Sabatine","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2015.12.003_bib0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.12.003_bib0160","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: A collaborative meta-analysis of randomized statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.12.003_bib0165","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.arteri.2015.12.003_bib0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2012.09.042","article-title":"Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy effect of baseline risk factors for diabetes","volume":"61","author":"Waters","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2015.12.003_bib0175","unstructured":"European Medicines Agency [Portal de internet] London: EMA; \u00a9 1995-2015 EMA Pharmacovigilance Working Party (PhVWP) December 2011. EMA\/CHMP\/PhVWP\/973945\/2011 [consultado 27 Sep 2015]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/enGB\/documentlibrary\/Report\/2012\/01\/WC500120115.pdf"},{"key":"10.1016\/j.arteri.2015.12.003_bib0180","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2015.12.003_bib0185","series-title":"The Delphi method: An experimental study of group opinion","author":"Dalkey","year":"1969"},{"key":"10.1016\/j.arteri.2015.12.003_bib0190","series-title":"The Delphi method, III: Use of self ratings to improve group estimates","author":"Dalkey","year":"1969"},{"key":"10.1016\/j.arteri.2015.12.003_bib0195","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arteri.2015.12.003_bib0200","series-title":"El grupo nominal en el entorno sanitario. Quaderns de Salut Publica i Administraci\u00f3 de Serveis de Salut 1","author":"Peir\u00f3","year":"2003"},{"key":"10.1016\/j.arteri.2015.12.003_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7340","article-title":"Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system","volume":"7","author":"Royle","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.arteri.2015.12.003_bib0210","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND\/UCLA Appropriateness Method User's Manual. 2001 [consultado 27 Sep 2015]. Disponible en: http:\/\/www.rand.org\/pubs\/monograph_reports\/MR1269.html"},{"key":"10.1016\/j.arteri.2015.12.003_bib0215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1214\/aoms\/1177705148","article-title":"Snowball sampling","volume":"32","author":"Goodman","year":"1961","journal-title":"Ann Math Stat"},{"key":"10.1016\/j.arteri.2015.12.003_bib0220","series-title":"Informe de resultados Menphis: consenso Delphi sobre la relevancia del manejo de la comorbilidad en el tratamiento del paciente con esquizofrenia","author":"Caballero","year":"2010"},{"key":"10.1016\/j.arteri.2015.12.003_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2014.04.001","article-title":"The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for the clinical practice","volume":"15","author":"Sattar","year":"2014","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.arteri.2015.12.003_bib0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2261-14-85","article-title":"Statins and the risk of type 2 diabetes mellitus: Cohort study using de UK clinical practice research datalink","volume":"14","author":"Macedo","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.arteri.2015.12.003_bib0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ebmed-2015-110236","article-title":"The statin diabetes conundrum: Short-term gain, long-term risk or inconvenient truth","volume":"20","author":"DuBroff","year":"2015","journal-title":"Evid Based Med"},{"key":"10.1016\/j.arteri.2015.12.003_bib0240","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.arteri.2015.12.003_bib0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arteri.2014.09.001","article-title":"Posicionamiento del Comit\u00e9 Espa\u00f1ol Interdisciplinario de Prevenci\u00f3n Cardiovascular y la Sociedad Espa\u00f1ola de Cardiolog\u00eda en el tratamiento de las dislipidemias. Divergencia entre las gu\u00edas europea y estadounidense","volume":"27","author":"Lobos Bejarano","year":"2015","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.arteri.2015.12.003_bib0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.arteri.2013.07.006","article-title":"Consecuci\u00f3n del objetivo terap\u00e9utico del colesterol de las lipoprote\u00ednas de baja densidad en las unidades de l\u00edpidos y riesgo vascular de la Sociedad Espa\u00f1ola de Arteriosclerosis","volume":"25","author":"Pedro-Botet","year":"2013","journal-title":"Clin Investig Arterioscler"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T13:20:39Z","timestamp":1536931239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916816000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0214916816000188"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2015.12.003","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consenso Delphi sobre el manejo de la dislipidemia en pacientes con alteraci\u00f3n del metabolismo de la glucosa: estudio Diana","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}